The Supreme Court will hear oral arguments on Monday in yet another dispute over the separation of powers. The case is a ...

Unless the Trump administration successfully defends the ACA, the HIV prevention drug PrEP, various screenings and other ...

There is hope in the fight against cryptococcal meningitis, the second leading cause of death in patients with advanced HIV ...

The prevalence of hepatitis C virus (HCV) has decreased over time among patients with HIV infection in the United States with the use of direct-acting antiviral (DAA) therapy, according to findings ...

Reese Marketos played the role of government prosecutor in a False Claims Act case about alleged off-label use of an HIV drug ...

Many Americans were relieved when the Supreme Court left the Affordable Care Act in place following the law's third major ...

After a group of employers refused to provide their employees access to free HIV prevention treatment, the Supreme Court may ...

Social barriers were linked to reduced access and low uptake of LAI PrEP and ART for HIV treatment and prevention.

among the first symptoms people experience when they go off HIV treatment. That's the word Theresa Mwanza, 32, liked to use ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

As London police move to crack down on illegal drug use in public spaces, the operator of the city's supervised drug ...

A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 — but only if between two and four million HIV-negative people in the country would need to use the jab ...